Extracellular Vesicles Tropism: A Comparative Study between Passive Innate Tropism and the Active Engineered Targeting Capability of Lymphocyte-Derived EVs
Open Access
Abstract
Cellular communications take place thanks to a well-connected network of chemical–physical signals, biomolecules, growth factors, and vesicular messengers that travel inside or between cells. A deep knowledge of the extracellular vesicle (EV) system allows for a better understanding of the whole series of phenomena responsible for cell proliferation and death. To this purpose, here, a thorough immuno-phenotypic characterization of B-cell EV membranes is presented. Furthermore, the cellular membrane of B lymphocytes, Burkitt lymphoma, and human myeloid leukemic cells were characterized through cytofluorimetry assays and fluorescent microscopy analysis. Through cytotoxicity and internalization tests, the tropism of B lymphocyte-derived EVs was investigated toward the parental cell line and two different cancer cell lines. In this study, an innate capability of passive targeting of the native EVs was distinguished from the active targeting capability of monoclonal antibody-engineered EVs, able to selectively drive the vesicles, enhancing their internalization into the target cancer cells. In particular, the specific targeting ability of anti-CD20 engineered EVs towards Daudi cells, highly expressing CD20 marker on their cell membrane, was proved, while almost no internalization events were observed in HL60 cells, since they did not express an appreciable amount of the CD20 marker on their plasma membranes.Keywords
Funding Information
- European Research Council (678151)
This publication has 53 references indexed in Scilit:
- Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLCOncoImmunology, 2016
- The biology and function of exosomes in cancerJournal of Clinical Investigation, 2016
- Cells release subpopulations of exosomes with distinct molecular and biological propertiesScientific Reports, 2016
- A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affectionsCritical Reviews in Oncology/Hematology, 2016
- Tumour exosome integrins determine organotropic metastasisNature, 2015
- Examination of the specificity of tumor cell derived exosomes with tumor cells in vitroBiochimica et Biophysica Acta (BBA) - Biomembranes, 2014
- How pure are your vesicles?Journal of Extracellular Vesicles, 2013
- Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological FluidsCurrent Protocols in Cell Biology, 2006
- Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomainsBlood, 2004
- Anti-CD20-based therapy of B cell lymphoma: state of the artLeukemia, 2002